ArticleScientific reports2015

PI3Kβ inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways.

Chenchen Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.